Dashboard
Manage Tickers

CCChemours Co

NYSE chemours.com


$ 18.70 $ 0.49 (2.69 %)    

Wednesday, 21-Aug-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.88 $ 2.24 (0.47 %)
DIA $ 408.91 $ 0.43 (0.11 %)
SPY $ 560.81 $ 1.92 (0.34 %)
TLT $ 98.72 $ 0.06 (0.06 %)
GLD $ 232.16 $ -0.31 (-0.13 %)
$ 18.7
$ 18.69 x 100
-- x --
-- - --
$ 14.76 - $ 33.74
790,453
na
2.79B
$ 1.83
$ 24.27
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 04-30-2024 03-31-2024 10-Q
3 03-27-2024 12-31-2023 10-K
4 10-27-2023 09-30-2023 10-Q
5 07-28-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 02-10-2023 12-31-2022 10-K
8 10-26-2022 09-30-2022 10-Q
9 07-29-2022 06-30-2022 10-Q
10 05-03-2022 03-31-2022 10-Q
11 02-11-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 07-30-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 02-12-2021 12-31-2020 10-K
16 11-04-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-14-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-03-2019 03-31-2019 10-Q
23 02-15-2019 12-31-2018 10-K
24 11-02-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 05-04-2018 03-31-2018 10-Q
27 02-16-2018 12-31-2017 10-K
28 11-03-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-03-2017 03-31-2017 10-Q
31 02-17-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 02-25-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-06-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

the-chemours-company-opens-chemours-battery-innovation-center-at-newark-delaware-focused-on-testing-and-scaling-next-generation-battery-technologies-for-sustainable-cost-effective-and-high-performing-ev-batteries
The Chemours Company Opens Chemours Batter...
08/13/2024 20:28:53

 Multi-Million-Dollar Investment Supports Hybrid And Electric Vehicle Advancements

jp-morgan-maintains-neutral-on-chemours-lowers-price-target-to-18
JP Morgan Maintains Neutral on Chemours, L...
08/06/2024 16:12:12

JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $25 to $18.

ubs-maintains-buy-on-chemours-lowers-price-target-to-28
UBS Maintains Buy on Chemours, Lowers Pric...
08/06/2024 15:34:39

UBS analyst Joshua Spector maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $30 to $28.

the-analyst-landscape-4-takes-on-chemours
The Analyst Landscape: 4 Takes On Chemours
08/06/2024 14:00:48

barclays-maintains-equal-weight-on-chemours-lowers-price-target-to-22
Barclays Maintains Equal-Weight on Chemour...
08/06/2024 13:12:04

Barclays analyst Michael Leithead maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $30 to $22.

bmo-capital-maintains-outperform-on-chemours-lowers-price-target-to-30
BMO Capital Maintains Outperform on Chemou...
08/06/2024 11:54:16

BMO Capital analyst John McNulty maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $35 to $30.

the-chemours-company-anticipates-a-low-to-mid-single-digit-sequential-decline-in-net-sales-for-q3
The Chemours Company Anticipates A Low To ...
08/01/2024 20:28:48

OutlookThe Company anticipates a low to mid-single digit sequential decline in Net Sales for the third quarter, reflective of:R...

chemours-q2-adj-038-misses-057-estimate-sales-154b-beat-153b-estimate
Chemours Q2 Adj $0.38 Misses $0.57 Estimat...
08/01/2024 20:28:01

Chemours (NYSE:CC) reported quarterly earnings of $0.38 per share which missed the analyst consensus estimate of $0.57 by 33.33...

wall-streets-most-accurate-analysts-views-on-3-materials-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts' View...
08/01/2024 13:55:36

ubs-upgrades-chemours-to-buy-raises-price-target-to-30
UBS Upgrades Chemours to Buy, Raises Price...
07/09/2024 12:56:44

UBS analyst Joshua Spector upgrades Chemours (NYSE:CC) from Neutral to Buy and raises the price target from $28 to $30.

reported-earlier-chemours-company-announced-that-the-mexican-government-has-lifted-its-prior-water-intake-restrictions-enabling-the-company-to-resume-normal-operations-at-its-titanium-dioxide-tio2-manufacturing-facility-in-altamira-mexico
Reported Earlier, Chemours Company Announc...
06/25/2024 06:55:05

how-is-the-market-feeling-about-chemours
How Is The Market Feeling About Chemours?
06/20/2024 18:00:25

what-analysts-are-saying-about-chemours-stock
What Analysts Are Saying About Chemours Stock
06/07/2024 13:00:23

mizuho-initiates-coverage-on-chemours-with-neutral-rating-announces-price-target-of-25
Mizuho Initiates Coverage On Chemours with...
06/07/2024 10:40:46

Mizuho analyst John Roberts initiates coverage on Chemours (NYSE:CC) with a Neutral rating and announces Price Target of $25.

the-chemours-company-announced-the-appointment-of-shane-hostetter-as-chief-financial-officer-cfo-effective-july-1-2024
The Chemours Company Announced The Appoint...
06/05/2024 10:32:41

wall-streets-most-accurate-analysts-views-on-3-materials-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts' View...
05/31/2024 13:26:16

chemours-discontinues-us-sales-of-legacy-freon-refrigerants-404a-and-507
Chemours Discontinues US Sales Of Legacy F...
05/02/2024 10:49:45

Chemours will discontinue U.S. sales of these select Freon products as of May 2, 2024, in support of regulatory phasedown requi...

chemours-expects-q2-consolidated-net-sales-to-increase-approximately-15-sequentially
Chemours Expects Q2 Consolidated Net Sales...
04/30/2024 20:52:07

Consolidated Adjusted EBITDA also to be up approximately 15% compared with first quarter 2024 results.

chemours-q1-2024-adj-eps-032-beats-018-estimate
Chemours Q1 2024 Adj EPS $0.32 Beats $0.18...
04/30/2024 20:31:31

Chemours (NYSE:CC) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.18 by 77.78 p...

chemours-q1-sales-1350b-beat-1349b-estimate
Chemours Q1 Sales $1.350B Beat $1.349B Est...
04/30/2024 20:29:56

Chemours (NYSE:CC) reported quarterly sales of $1.350 billion which beat the analyst consensus estimate of $1.349 billion by 0....

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION